$5 million was raised by Redwood City, California-based Bone Health Technologies, a health technology startup.
Berkeley Catalyst Fund, Esplanade Ventures, Terumo Medical, a medical technology company, and a strategic investor participated in the financing.
The money will help the company finish developing its flagship Osteoboost vibration wearable, which should appear later this year.
BHT, led by CEO Laura Yecies, uses science and medical knowledge to improve the health of men and women who are at risk of osteoporosis and the resulting bone fractures.
Osteoboost, the company’s first FDA-approved device, attempts to treat postmenopausal osteopenia as a new standard of care.
Yushin Yazaki of Terumo and Ella Seitz of Esplanade Ventures were named board observers.
About Bone Health Technologies
A Redwood City-based business called Bone Health Technologies (BHT) uses science and medical knowledge to improve health outcomes for both men and women who are susceptible to osteoporosis and the bone fractures that come with it. Osteoboost, the company’s first FDA-approved device, is set to replace post-menopausal osteopenia as the new standard of care. Prominent investors, such as Golden Seeds, Esplanade Ventures, Ambit Health Ventures, Good Growth Capital, Portfolia, and Astia Angels, support BHT.
